parecoxib has been researched along with Carcinoma, Hepatocellular in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, N; Kong, Y; Lai, J; Li, J; Li, X; Lyu, N; Zhao, M | 1 |
| Ge, YS; Jia, WD; Wang, RD; Xu, GL; Zhu, JY; Zhu, Y | 1 |
| Feng, ZY; Gao, YP; Guo, JG; Guo, XJ; Lu, XY; Rao, YF; Sun, JH; Zhao, LP; Zhou, TY | 1 |
| Jia, WD; Li, YQ; Lv, JG; Qiao, XF; Zhou, H | 1 |
| Kong, Y; Lv, N; Mu, L; Pan, T; Xie, Q; Zhao, M | 1 |
| Chen, JB; Chen, JC; Chen, MS; Qiu, HB; Wang, RJ; Xu, L; Zhang, YJ; Zhou, ZG | 1 |
4 trial(s) available for parecoxib and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Effect and Safety of Prophylactic Parecoxib for Pain Control of Transarterial Chemoembolization in Liver Cancer: A Single-Center, Parallel-Group, Randomized Trial.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Isoxazoles; Liver Neoplasms; Pain, Postoperative; Prospective Studies | 2022 |
Perioperative analgesia with parecoxib sodium improves postoperative pain and immune function in patients undergoing hepatectomy for hepatocellular carcinoma.
Topics: Analgesics, Opioid; Carcinoma, Hepatocellular; Hepatectomy; Humans; Immunity; Isoxazoles; Liver Neoplasms; Pain, Postoperative | 2020 |
Effectiveness of Parecoxib Sodium Combined with Transversus Abdominis Plane Block for Pain Management After Hepatectomy for Hepatocellular Carcinoma: A Prospective Controlled Study.
Topics: Abdominal Muscles; Adult; Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Local; Carcinoma, Hepatocellular; China; Female; Hepatectomy; Humans; Isoxazoles; Liver Neoplasms; Male; Middle Aged; Nerve Block; Pain Management; Pain Measurement; Pain, Postoperative; Postoperative Complications; Prospective Studies; Ropivacaine | 2019 |
Effect of perioperative parecoxib sodium on postoperative pain control for transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma: a prospective randomized trial.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; Isoxazoles; Liver Neoplasms; Male; Middle Aged; Pain, Postoperative; Perioperative Care; Prospective Studies; Treatment Outcome | 2016 |
2 other study(ies) available for parecoxib and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Analgesia, Patient-Controlled; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Isoxazoles; Liver Neoplasms; Male; Middle Aged; Pain, Postoperative; Patient Satisfaction; Postoperative Nausea and Vomiting; Sufentanil | 2018 |
Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cyclooxygenase 2 Inhibitors; Female; Fever; Humans; Isoxazoles; Length of Stay; Liver; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Palliative Care; Postoperative Nausea and Vomiting; Propensity Score; Prospective Studies | 2016 |